Search

Search Constraints

You searched for: Author/Creator Fenske, Timothy S.

Search Results

1. A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B‐cell non‐Hodgkin lymphoma: A Wisconsin Oncology Network study. Issue 19 (16th June 2015)

2. Allogeneic haematopoietic cell transplantation for extranodal natural killer/T‐cell lymphoma, nasal type: a CIBMTR analysis. (2nd August 2017)

3. Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation. (15th March 2016)

4. Autologous haematopoietic cell transplantation for non‐Hodgkin lymphoma with secondary CNS involvement. (6th July 2013)

5. Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy. Issue 11 (26th March 2018)

7. C‐MYC–positive relapsed and refractory, diffuse large B‐cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy. Issue 22 (27th July 2017)

8. De novo CD5+ diffuse large B‐cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort. Issue 4 (18th March 2016)

9. De novo CD5+ diffuse large B‐cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort. Issue 4 (June 2016)

10. Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma. Issue 12 (2nd December 2018)